Pitcairn Co. Has $1,195,000 Stake in Clorox Co. (CLX)
Pitcairn Co. increased its position in shares of Clorox Co. (NYSE:CLX) by 3.4% during the second quarter, Holdings Channel reports. The firm owned 8,634 shares of the company’s stock after buying an additional 284 shares during the period. Pitcairn Co.’s holdings in Clorox were worth $1,195,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CLX. Invictus RG bought a new position in Clorox during the first quarter worth approximately $110,000. Checchi Capital Advisers LLC increased its position in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Mutual of Omaha Bank Wealth Management increased its position in Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock worth $226,000 after buying an additional 300 shares during the period. Paragon Capital Management Ltd bought a new position in Clorox during the second quarter worth approximately $232,000. Finally, Douglas Lane & Associates LLC bought a new position in Clorox during the first quarter worth approximately $262,000. 70.17% of the stock is owned by institutional investors and hedge funds.
Clorox Co. (NYSE:CLX) traded up 0.63% during mid-day trading on Tuesday, hitting $123.44. The stock had a trading volume of 1,120,012 shares. Clorox Co. has a 52 week low of $113.37 and a 52 week high of $140.47. The company’s 50 day moving average price is $129.50 and its 200 day moving average price is $130.10. The firm has a market cap of $15.98 billion, a PE ratio of 25.09 and a beta of 0.33.
Clorox (NYSE:CLX) last issued its earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.28 by $0.02. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The company earned $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the business earned $1.44 EPS. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. Analysts anticipate that Clorox Co. will post $5.49 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Shareholders of record on Wednesday, October 26th will be paid a $0.80 dividend. The ex-dividend date of this dividend is Monday, October 24th. This represents a $3.20 annualized dividend and a yield of 2.59%. Clorox’s dividend payout ratio is currently 64.91%.
A number of research analysts recently commented on CLX shares. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $148.00 price target for the company in a research note on Monday, August 8th. Atlantic Securities raised Clorox from a “hold” rating to a “buy” rating and set a $144.00 price target for the company in a research note on Friday. Jefferies Group reaffirmed a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Deutsche Bank AG reissued a “hold” rating and set a $134.00 target price (up previously from $130.00) on shares of Clorox in a research note on Sunday, July 24th. Finally, B. Riley reissued a “neutral” rating and set a $109.00 target price on shares of Clorox in a research note on Tuesday, August 9th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $128.90.
In other Clorox news, SVP Jon M. Balousek sold 5,136 shares of the firm’s stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $131.14, for a total value of $673,535.04. Following the completion of the transaction, the senior vice president now owns 15,384 shares in the company, valued at approximately $2,017,457.76. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Dawn C. Willoughby sold 10,617 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $131.01, for a total value of $1,390,933.17. Following the completion of the transaction, the chief operating officer now owns 20,353 shares of the company’s stock, valued at approximately $2,666,446.53. The disclosure for this sale can be found here. 2.09% of the stock is owned by company insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.